Helixgate

Helixgate

Uncategorized

Windward Bio gets $165M to take China-derived drug into Phase 3 asthma trial

Published

on

A Swiss biotech with two experimental medicines from China, plus an in-house discovery team, has brought in $165 million to advance into late-stage testing.

The startup, Windward Bio, has raised a …

Continue Reading
Click to comment

Leave a Reply

Your email address will not be published. Required fields are marked *

Uncategorized

Supreme Court restores access to abortion pill mifepristone through telehealth, mail, and pharmacies

WASHINGTON — The Supreme Court on Monday restored broad access to the abortion pill mifepristone, blocking a ruling that had threatened to upend one of the main ways abortion is provided across the nation.

The order signed by Justice Samuel Alito temporarily allows women seeking abortions to obtain the pill at pharmacies or through the mail, without an in-person visit to a doctor.

Read the rest…

Read More

Published

on

WASHINGTON — The Supreme Court on Monday restored broad access to the abortion pill mifepristone, blocking a ruling that had threatened to upend one of the main ways abortion is provided across the nation.

The order signed by Justice Samuel Alito temporarily allows women seeking abortions to obtain the pill at pharmacies or through the mail, without an in-person visit to a doctor.

Read the rest…

Read More

Continue Reading

Uncategorized

Celcuity breast cancer win; Odyssey plans $205M IPO; Latus Bio extends Series A

Published

on

Celcuity’s breast cancer drug wins again: The company said two regimens with its experimental drug gedatolisib succeeded in PIK3CA mutant patients as part of its Phase 3 trial. Last year …

Continue Reading

Uncategorized

STAT+: Pump the brakes on AI, buddy; and deposition deadlock

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Hey! Are you going to be in Washington, D.C. on May 19? I’ll be moderating a Georgetown University panel discussion on vertical integration in health care. Jonathan Kanter, the former top antitrust official at the Department of Justice, also will make remarks. It’s gonna be lit. Reserve a spot here. And as always, a penny for your thoughts: bob.herman@statnews.com.

The Elevance exec you need to know

Lawsuits alleging health insurers defrauded Medicare and other government programs take forever to litigate. Maybe they’re more about the friends you make along the way.

Continue to STAT+ to read the full story…

Read More

Published

on

This is the online version of STAT’s weekly email newsletter Health Care Inc. Sign up here.

Hey! Are you going to be in Washington, D.C. on May 19? I’ll be moderating a Georgetown University panel discussion on vertical integration in health care. Jonathan Kanter, the former top antitrust official at the Department of Justice, also will make remarks. It’s gonna be lit. Reserve a spot here. And as always, a penny for your thoughts: bob.herman@statnews.com.

The Elevance exec you need to know

Lawsuits alleging health insurers defrauded Medicare and other government programs take forever to litigate. Maybe they’re more about the friends you make along the way.

Continue to STAT+ to read the full story…

Read More

Continue Reading
Advertisement

Trending